project id: TCGA-LUAD; case submitter id: TCGA-55-A48X; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 63; days to birth: -23341; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23341; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 689.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 1.9726027397260273; pack years smoked: 36.0; years smoked: 36.0; is ffpe: false; composition: Not Reported; days to collection: 111; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-55-A48X-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 70.0;